World Class Leadership

WorldCare Clinical (WCC) has assembled a world-class leadership team that guides our pursuit of excellence in clinical trial imaging.

Members of WorldCare Clinical’s (WCC) executive management team include:
 
Stephen Pomeranz, M.D., Chairman. Dr. Pomeranz is the founder, chief executive officer, and medical director of ProScan Imaging, Inc. and ProScan MRI Education Foundation. He is a consultant to over 350 medical and imaging institutions, the author of several acclaimed medical imaging texts, and the lead radiologist for WCC’s in-house radiology team. The founder of the Clinical Magnetic Resonance Society (CMRS), Pomeranz is also an assistant clinical professor of radiology at the University of Louisville and a volunteer instructor in the Department of Orthopaedic Surgery at the University of Cincinnati Medical Center.  A graduate of Brown University and the University of Cincinnati College of Medicine, he is board-certified in radiology, is a musculoskeletal radiologist and a neuroradiologist (with a Certificate of Added Qualification), and has completed fellowships in MRI, CT, nuclear medicine, ultrasound, and special procedures.

Michael D. O’Brien, Managing Director. Mr. O’Brien is managing director of WorldCare Clinical and chief operating officer of ProScan Imaging, the largest independent teleradiology operation in the country. Previously Mr. O’Brien was president of Zoomtown.com and president of Chiquita International. He worked for 12 years at Procter and Gamble.
 
Rafael Mancera, Chief Financial Officer. Mr. Mancera became WCC’s CFO in 2008. Prior to that, he was chief operating officer at ProScan Clinical Trials Imaging (PCTI) at ProScan Imaging LLC, WCC’s parent company, and treasurer and senior director of mergers and acquisitions at Kendle International Inc. Before joining Kendle, Mr. Mancera held senior leadership positions at Benefit Designs, Inc. and Banco Nacional de Mexico, S.A., Mexico’s leading bank. He received a B.S. degree in industrial engineering from Universidad Iberoamericana and an M.B.A. from Northwestern University’s J.L. Kellogg Graduate School of Management.
 
Richard Walovitch, Ph.D., Chief Medical Officer. Dr. Walovitch is chief medical officer of WorldCare Clinical. Prior to joining WCC, he served as the senior vice president of clinical research at Acusphere, Inc., vice president of preclinical and clinical research at Epix Medical, and held various positions as research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
 
Richard Taranto, Executive Vice President, Business Development. Mr. Taranto is executive vice president of business development at WorldCare Clinical.  Since joining WCC in 2002, he has managed multiple clinical imaging trials for biopharmaceutical and medical device companies, including more than 25 Phase II-IV studies, and developed and implemented management tools to streamline organizational effectiveness. Before coming to WCC, Mr. Taranto was senior project manager at Perceptive Informatics. He earned a B.S. degree in zoology from the University of Rhode Island and an M.B.A. from Boston College.
 
John Tomera, Ph.D., Director of Regulatory Affairs & Associate Medical Director. Mr. Tomera is director of regulatory affairs and associate medical director of WorldCare Clinical. Prior to joining WCC, he served as director of regulatory affairs at Biopure Corporation in Cambridge and clinical development director of oncology agents at Point Therapeutics. Tomera holds a doctorate in pharmacology from Temple University School of Medicine, and a B.S. from the University of Pittsburgh. He has also held postdoctoral posts at the Harvard School of Public Health and at the Massachusetts Institute of Technology (MIT). Subsequently, he held a faculty position as an assistant professor of anaesthesiology (pharmacology) at Harvard Medical School, with appointments in the Anesthesia Services at the Massachusetts General Hospital and Shriners Burns Institute in Boston.